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Skeletal developmentin various cellular processes, the functions of Akt and Akt downstream signaling
pathways in the cellular processes of skeletal development remain to be clariﬁed. By analyzing transgenic
embryos that expressed constitutively active Akt (myrAkt) or dominant-negative Akt in chondrocytes, we
found that Akt positively regulated the four processes of chondrocyte maturation, chondrocyte proliferation,
cartilage matrix production, and cell growth in skeletal development. As phosphorylation of GSK3β, S6K, and
FoxO3a was enhanced in the growth plates of myrAkt transgenic mice, we examined the Akt downstream
signaling pathways by organ culture. The Akt-mTOR pathway was responsible for positive regulation of the
four cellular processes. The Akt-FoxO pathway enhanced chondrocyte proliferation but inhibited
chondrocyte maturation and cartilage matrix production, while the Akt-GSK3 pathway negatively regulated
three of the cellular processes in limb skeletons but not in vertebrae due to less GSK3 expression in vertebrae.
These ﬁndings indicate that Akt positively regulates the cellular processes of skeletal growth and
endochondral ossiﬁcation, that the Akt-mTOR, Akt-FoxO, and Akt-GSK3 pathways positively or negatively
regulate the cellular processes, and that Akt exerts its function in skeletal development by tuning the three
pathways in a manner dependent on the skeletal part.
© 2009 Elsevier Inc. All rights reserved.Introduction
Endochondral ossiﬁcation, a process involving a cartilage interme-
diate, is responsible for the formation of most vertebrate skeletal ele-
ments including the chondrocranium, vertebral column, ribs, scapulae,
pelvis, and limb bones (DeLise et al., 2000). After condensation of me-
senchymal chondroprogenitor cells, cells differentiate into chondro-
cytes, which express cartilaginous matrix molecules and form cartilage
that preﬁgures future skeletal elements. Endochondral bone growth
takes place at the growth plate, where chondrocytes undergo unidirec-
tional proliferation and then maturate to become hypertrophic chon-
drocytes. Hypertrophic chondrocytes eventually undergo apoptosis and
are replaced by bone cells (Nakashima and de Crombrugghe, 2003).
Akt/protein kinase B (PKB), which belongs to the family of serine/
threonine protein kinases, has been highly conserved throughout evo-
lution (Datta et al., 1999). Akt1 and Akt2 share extensive sequence
homology at the amino acid level, whereas Akt3 is slightly more diver-
gent in structure and is expressed as a splice variant that lacks a
regulatory phosphorylation site (Brodbeck et al., 2001). Akt protein
kinases are stimulated by a number of receptor tyrosine kinases and Genhanced green ﬂuorescence
(H), transgenic mice with high
inant negative.
i).
l rights reserved.protein-coupled receptors (Kandel andHay,1999; Brazil and Hemmings,
2001; Lawlor and Alessi, 2001) through phosphatidylinositol 3-kinase
(PI3K) (Cantley, 2002). The lipid product of PI3K, PIP3 (phosphatidyli-
nositol 3,4,5 triphosphate), recruits both PDK1 and Akt to the plasma
membrane. Akt is subsequently phosphorylated on T308 by PDK1 and
on S473 by mTORC2 (consisting of mTOR, mLST8, and Rictor), leading
to full activation (Sarbassov et al., 2005; Corradetti and Guan, 2006).
Insulin-like growth factor (IGF) is an anabolic growth factor required
for fetal and postnatal development, and IGF signaling regulates both
embryonic and postnatal body/organ size, as evidenced by general
growth retardation of Igf1- or Igf1r-deﬁcient mice (Baker et al., 1993;
Liu et al.,1993; Powell-Braxton et al.,1993). Most of the circulating IGF-I
is produced by the liver and transported to other tissues, acting as an
endocrine hormone. IGF-I is also produced by many tissues, including
bone cells and chondrocytes, and acts locally as an autocrine/paracrine
hormone (Le Roith et al., 2001). Genetic approaches revealed that the
IGFs-IGF receptor-PI3K-Akt pathway plays key roles in skeletal growth
and endochondral ossiﬁcation. Igf1-deﬁcient mice, Igf1r-deﬁcient mice,
and Akt1/Akt2-deﬁcient mice showed retarded skeletal growth and
endochondral ossiﬁcation, while conditional Pten-deﬁcient mice
showed accelerated skeletal growth and chondrocyte maturation
(Baker et al., 1993; Liu et al., 1993; Powell-Braxton et al., 1993; Peng
et al., 2003; Wang et al., 2006; Ford-Hutchinson et al., 2007).
Akt activates or inhibits many molecules including GSK3, TSC2,
FoxOs, BAD, MDM2, Caspase 9, AS160, eNOS, and PRAS40 by phos-
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such as metabolism, growth, differentiation, proliferation, survival,
glucose uptake, and angiogenesis. Akt regulates the activities of
three FoxO proteins, FoxO1/FKHR, FoxO3a/FKHRL1, and FoxO4/AFX
(Brunet et al., 1999), which have overlapping patterns of expression
and transcriptional activities (Anderson et al., 1998; Furuyama et al.,
2000). Following activation by PI3K, Akt rapidly phosphorylates FoxO
proteins. The phosphorylated FoxO proteins associate with the 14-3-3
protein, which functions as a scaffold within the cytoplasm, and are
sequestered within the cytosol, rendering them unable to bind to the
promoters of their target genes in the nucleus to regulate their trans-
cription. In mammals, FoxO subfamily members regulate diverse cell
functions such as apoptosis, cell cycle progression, and DNA repair
(Accili and Arden, 2004). However, the functional redundancy of FoxO
subfamily members makes it difﬁcult to clarify the function of FoxOs
in skeletal development (Castrillon et al., 2003; Hosaka et al., 2004).
Akt also regulates the activities of two glycogen synthase kinase 3
(GSK3) proteins, GSK3α and GSK3β (Frame and Cohen, 2001). There are
threemajor pools of GSK3 under the basal condition: (1) GSK3 is part of
theWnt signaling complex, which consists of Axin, β-catenin, and other
proteins; (2) GSK3 is part of the hedgehog signaling complex, which
consists of Cos2, Gli, and other proteins; and (3) there is a free pool of
GSK3. Following the binding of Wnt to its receptors, Axin is displaced
from GSK3, leading to the stabilization of β-catenin, its accumulation in
the nucleus, its binding with members of the Lef/Tcf family of
transcription factors, and transcriptional activation of Wnt target
genes (Frame and Cohen, 2001). Hedgehog signaling displaces Cos2
from GSK3, inhibiting Gli processing and directing the accumulation of
full-length Gli and the transcriptional activation of hedgehog-response
genes (Kim and Kimmel, 2006). In the free pool of GSK3, Akt inhibits
GSK3 proteins by phosphorylating Ser21 in GSK3α and Ser9 in GSK3β.
As a result, the residues on glycogen synthase undergo partial depho-
sphorylation, thereby increasing their activity and hence stimulating
glycogen synthesis. GSK3 is a ubiquitously expressed kinase that
regulates diverse cellular processes ranging from metabolism to cell
fate speciﬁcation (Cohen and Frame, 2001). The involvement of GSK3 in
multiple signaling pathways makes it difﬁcult to clarify the function of
the Akt-GSK3 pathway in skeletal development.
Akt activates mTOR through TSC2 and Rheb (Corradetti and Guan,
2006), and activated mTOR plays several important roles in mRNA
translation mediated through eukaryotic initiation factor 4E (eIF-4E),
which is essential for cap-dependent initiation of translation and
promotion of cell growth (Hay and Sonenberg, 2004), and through S6K,
which has been implicated in ribosome biogenesis as well as modi-
ﬁcation of the ribosomal protein, S6 (Hannan et al., 2003). As the IGFs-
IGF receptor-PI3K-Akt pathway plays important roles in skeletal dev-
elopment, it is pivotal to clarify the functions of Akt and each of the Akt
downstream signaling axes in skeletal development and the molecular
linkage to chondrocyte maturation, proliferation, and function.
To pursue these issues, we investigated the roles of Akt signaling
pathways during skeletal development, focusing on GSK3, mTOR,
and FoxOs, which are predicted to play important roles among the
many Akt downstream signaling molecules in the cellular processes
of skeletal development. By generating and analyzing chondrocyte-
speciﬁc constitutively active Akt or dominant negative (dn)-Akt trans-
genic mice and using organ culture of limb and vertebral skeletons, we
show here that chondrocyte maturation and proliferation and carti-
lage matrix production are regulated by the balance of the three Akt
downstream signaling axes of GSK3, mTOR, and FoxOs.
Results
Generation of myrAkt transgenic mice
To examine the role of Akt in endochondral ossiﬁcation, we gene-
rated transgenic mice that express constitutively active Akt (myr-istoylated Akt; myrAkt) and enhanced green ﬂuorescence protein
(EGFP) speciﬁcally in chondrocytes using the Col2a1 promoter (Fig.
1A). As many of the F0 transgenic mice could not survive after birth,
we analyzed the transgenic mice at embryonic stages. We selected 64
F0 embryos with EGFP expression from a total of 747 embryos (Fig.1B).
To estimate expression levels of the transgene, all embryos were
selected by EGFP intensities, and the expression level of the transgene
in some EGFP-positive embryos was analyzed by Northern blot
analysis with the Akt probe (Fig. 1C). The transgenic embryos whose
expression level of the transgene was less than half of that of
endogenous Akt were classiﬁed as tg(L), and the transgenic embryos
whose expression level of the transgene was more than half of that of
endogenous Akt were classiﬁed as tg(H). The other EGFP-positive
embryos were classiﬁed as tg(L) (total 39 pups) or tg(H) (total 25 pups)
by comparing the intensities of EGFP. The body size of tg(L) was
enlarged, but the limbs of tg(H) were shortened (Fig. 1B). The EGFP
signals in the embryos at embryonic day 18.5 (E18.5) showed that the
transgene was expressed in a cartilage-speciﬁc manner (Fig. 1D), and
the signals were strongly detected in resting and proliferating chon-
drocytes (Figs. 1E, F). Immunohistochemistry using anti-GFP antibody
showed that some of the hypertrophic chondrocytes, which were
enlarged, also expressed the transgene strongly (Fig. 1G), although the
number of the hypertrophic chondrocytes, which strongly expressed
transgene, was limited and variable in individual F0 transgenic mouse
(data not shown).
myrAkt transgenic mice had thickened limb skeletons with reduced
mineralization and enlarged craniobasal and vertebral skeletons with
enhanced mineralization
To assess the process of endochondral ossiﬁcation in myrAkt
transgenic mice, the skeletons at E15.5 and E18.5 were stained with
Alcian blue and Alizarin red to detect cartilage and calciﬁed tissue,
respectively (Figs. 1H–O). All of the skeletal elements of endochondral
bones, including limb bones, ribs, craniobasal bones, and vertebrae,
were thickened or enlarged in tg(L) at E15.5 (Figs. 1H–J, data not
shown) and E18.5 (Figs. 1K–O). Themineralization of limb skeletons in
tg(L) was reduced compared with that in wild-type mice at E15.5
(Figs. 1H, I). In tg(H), the limb skeletons, sternum, and ribs were thick
but the length was diminished and the mineralization of limb ske-
letons was reduced compared with those in wild-type embryos at
E18.5 (Figs. 1K–M). However, the mineralization of the sphenoid bone,
basioccipital bone, and vertebrae was advanced in myrAkt transgenic
mice in a manner dependent on transgene expression (Figs.1N and O).
Further, the primordium of the petrous part of the temporal bone was
mineralized in tg(L) and tg(H) but not in wild-type embryos (Fig. 1N).
These ﬁndings indicate that constitutive activation of Akt in chon-
drocytes thickens or enlarges all of the endochondral bones and
enhances mineralization of the craniobasal and vertebral skeletons
but inhibits mineralization of limb skeletons, and that high expres-
sion of constitutively active Akt inhibits longitudinal growth of limb,
sternum, and rib skeletons.
Deceleration of chondrocyte maturation in limb skeletons and
acceleration of chondrocyte maturation in craniobasal and vertebral
skeletons of myrAkt transgenic mice
As endochondral ossiﬁcation was retarded in limb skeletons of
myrAkt transgenic mice (Figs. 1H, I, K, L), we examined chondrocyte
maturation in tibiae at E13.5 and E15.5 by in situ hybridization (Fig. 2).
At E13.5, Col2a1mRNA, which is expressed in resting and proliferating
chondrocytes, was detected in wild-type, tg(L), and tg(H) tibiae, while
Pthr1mRNA, which is expressed in prehypertrophic chondrocytes and
early hypertrophic chondrocytes, was detected in wild-type tibiae but
was barely detectable in tg(L) and tg(H) tibiae (Figs. 2A–C). At E15.5,
the length of the proliferating chondrocyte layer was diminished in
Fig. 1. Generation of myrAkt transgenic mice and examination of the skeletal system. (A) Diagram of the DNA construct used to generate Col2a1-myrAkt transgenic mice. ⁎SV40 splice
donor/acceptor sequences, ⁎⁎SV40 polyadenylation sequence. (B) Gross appearance and EGFP ﬂuorescence of wild-type (wt) mouse, tg(L), and tg(H) at E15.5. The pictures of bright
ﬁeld (upper panel) and dark ﬁeld (lower panel) are shown. (C) Northern blot analysis with the Akt probe. RNA was extracted from the skeletons of wild-type mice (wt), tg(L), and
tg(H) at E18.5. The arrowhead shows endogenous AktmRNA and the arrow shows transgenemRNA. (D–G) EGFP ﬂuorescence inwhole femurs (D) and in the frozen sections of femurs
(F) and immunohistochemical analysis of EGFP protein using the parafﬁn-embedded sections of femurs (G) fromwild-type mouse and tg(L) at E18.5. Sections in F were stained with
HE (E). A nonspeciﬁc ﬂuorescent signal was detected in the region of the primary spongiosa and bone collar (F). The sections in G were counterstained with methyl green. (H–O)
Skeletal system at E15.5 (H–J) and E18.5 (K–O). Forelimbs (H, K), hind limbs (I, L), cranial bases (J, N), thoracic cages (M), and vertebrae (O) of wild-type mice, tg(L) and tg(H) are
shown. Asterisks show sphenoid bones, arrowheads show basioccipital bones, and arrows show the petrous part of the temporal bones (N). Scale bars: (B, D, J, N, O) 1 mm; (E–G)
200 μm; (H, I, K, M) 2 mm; (L) 3 mm.
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dependent on transgene expression (Figs. 2D, 3A, B, F, G). In situ
hybridization of wild-type tibiae at E15.5 showed the following:
Col2a1 mRNA was detected in the epiphyses; Pthr1 and Col10a1
mRNAs, the latter of which is expressed in hypertrophic chondrocytes,
were detected in themetaphyses; and Spp1mRNA, which is expressed
in terminal hypertrophic chondrocytes and osteoblasts, was detected
in the diaphysis (Figs. 2E–H). In tg(L) and tg(H), however, Col2a1
mRNA was detected in the epiphyses and metaphyses, Pthr1 and
Col10a1 mRNAs were detected in the diaphyses, and Spp1 mRNA was
not detected (Figs. 2E–H), indicating that chondrocyte maturationwas
retarded in myrAkt transgenic mice. The mRNA of Ihh, which plays
important roles in chondrocyte maturation and proliferation, was
detected in prehypertrophic chondrocytes and early hypertrophic
chondrocytes at similar levels in wild-type mice, tg(L), and tg(H) at
E15.5 (Supplementary Fig. 1A, data not shown).
As endochondral ossiﬁcation was accelerated in craniobasal and
vertebral skeletons (Figs. 1J, N, and O), we examined chondrocyte
maturation at E15.5 by von Kossa staining and in situ hybridization.
In wild-type mice, the basioccipital bone was not mineralized and
Col10a1 expression was detected in the middle part of this bone
(Figs. 2I and J). In tg(L), however, the basioccipital bone was enlarged,
a large area of the bone was mineralized, and the mineralized area
separated the two Col10a1-positive layers by a large distance. Hyper-
trophy accompanying Col10a1 expression was evident in the verte-
brae of tg(L) compared with wild-type mice (Figs. 2K and L). These
ﬁndings indicate that chondrocyte maturation was accelerated in
craniobasal cartilaginous elements and vertebrae of myrAkt trans-
genic mice.
We next examined the expression levels of Pthlh, Ihh, and Runx2
by real-time RT-PCR using the RNA from long bones and vertebrae at
E15.5. The levels of Pthlh, Ihh and Runx2mRNA expression in the limb
and vertebral skeletons did not signiﬁcantly differ between wild-type
mice and tg(L) (Supplementary Fig. 1C).
Enhanced chondrocyte proliferation in vertebrae and in resting but not in
proliferating layers of limb skeletons and increased cartilage matrix in
myrAkt transgenic mice
As the length of the proliferating layer of tibiae was diminished in
myrAkt transgenic mice, we examined chondrocyte proliferation in
tibiae at E15.5 by BrdU labeling (Figs. 3A–E). The frequency of BrdU-
positive cells in the resting layer of tg(L) was increased comparedwith
that in wild-type mice, whereas the frequency in the proliferating
layer of tg(L) was reduced (Figs. 3A, B, E). In vertebrae, the frequency
of BrdU-positive cells was increased throughout the entire region
except the hypertrophic zone in tg(L) compared with wild-type mice
(Figs. 3C–E).
To evaluate the effect of Akt activation on cartilage matrix pro-
duction, we performed staining with safranin O, which stains
proteoglycans, and immunohistochemical analysis of type II
collagen using sections from tibiae and vertebrae (Figs. 3F–N).
Although the intensities of staining with safranin O and immunor-
eactivity against type II collagen in tibiae or vertebrae were similar
between wild-type mice and tg(L), the extracellular matrix area was
increased in the resting and proliferating layers of tibiae and in the
vertebrae of tg(L) compared with wild-type mice (Figs. 3F–N).
Further, limb mesenchymal cells from tg(L) at E12.5 produced more
cartilaginous matrix than those from wild-type mice in vitro (Fig.
3O). These ﬁndings indicate that extracellular matrix production
was enhanced in tg(L). As the levels of aggrecan and Col2a1 mRNA
expression seemed to be similar between wild-type and myrAkt
transgenic mice, it is suggested that cartilage matrix production
was enhanced at the post-transcriptional level (Fig. 2E, Supple-
mentary Fig. 1B). Cell size of chondrocytes was also enlarged in the
proliferating layer of tibiae and in the region without hypertrophyin the vertebrae of tg(L) (Fig. 3P). Further, the size of the
hypertrophic chondrocytes in tibiae of tg(L) was approximately
1.5-fold of that in wild-type mice (Fig. 3P). The resting layer in tg(L)
was enlarged due to the increased chondrocyte proliferation and
matrix production, whereas the proliferating layer was shortened
due to the reduced chondrocyte proliferation and the columnar
structure was disorganized due to the increased matrix production
and increased cell size (Figs. 3A, B, E, H, I, N, P). No vascular
invasion was observed in the resting and proliferating layers of
growth plates in tg(L) and tg(H) (Figs. 2, 3).
Endochondral ossiﬁcation was retarded in the whole skeleton of dn-Akt
transgenic mice
We also generated transgenic mice expressing dn-Akt, which
inhibited PDGF-induced phosphorylation of Akt in ATDC5 cells
(Supplementary Fig. 2A), under the control of the Col2a1 promoter
(Supplementary Fig. 2B–D). We obtained 46 F0 transgenic embryos
with an EGFP signal from a total of 521 embryos. However, only 3 F0
transgenic embryos had high transgene expression, the level of
which was similar to that of endogenous Akt, and their data are
shown here. The other 43 F0 transgenic embryos had a low level of
transgene expression of less than half of that of endogenous Akt, and
their phenotype did not signiﬁcantly differ from that of wild-type
littermates (data not shown), probably due to the high level of
endogenous Akt expression (Supplementary Fig. 2D). At E15.5, the
skeleton was smaller and thinner and mineralization of the limbs,
ribs, and cervical vertebrae was reduced in dn-Akt transgenic mice
compared with wild-type mice (Figs. 4A, B). The retardation of
endochondral ossiﬁcation was due to the deceleration of chondro-
cyte maturation, as shown by the delayed appearance of hyper-
trophic chondrocytes that express Col10a1 in the tibia and
basioccipital bone (Figs. 4C–J). At E18.5, the vertebral bodies were
smaller and less mineralized and chondrocyte hypertrophy accom-
panied by Col10a1 expression was delayed in dn-Akt transgenic mice
compared with wild-type mice (Figs. 4K–O). Cartilage matrix
production and chondrocyte proliferation were reduced in both
the resting and proliferating layers of tibiae of dn-Akt transgenic
mice compared with wild-type mice (Figs. 4P–S, Supplementary Fig.
2E). Apoptotic cells were rare in the resting and proliferating layers
of growth plates in wild-type mice, tg(L), and dn-Akt transgenic mice
by TUNEL staining, although TUNEL-positive cells were observed in
the corresponding layers of tg(H) (data not shown). These ﬁndings
indicate that dn-Akt inhibited chondrocyte maturation, chondrocyte
proliferation and cartilage matrix production, leading to the small
skeleton.
Expression of Akt, Akt downstream signaling molecules, GSK3β, S6K, and
FoxO3a, and their phosphorylated forms in growth plates
We examined the expression of Akt, GSK3β, S6K, FoxO3a, and their
phosphorylated forms in the growth plates of wild-type and myrAkt
transgenic mice by immunohistochemistry (Fig. 5). Akt and phos-
phorylated Akt were detected in all regions of the growth plates of
wild-type and myrAkt transgenic mice with higher levels in myrAkt
transgenic mice (Figs. 5A–D). GSK3β was weakly expressed in the
resting chondrocytes, upregulated in the proliferating layer, and
strongly expressed in the hypertrophic chondrocytes in both wild-
type and myrAkt transgenic mice (Figs. 5E, F). Phosphorylated GSK3β
was detected in a similar pattern inwild-typemice, but it was strongly
detected in all regions of the growth plates of myrAkt transgenic mice
(Figs. 5G, H). S6K, FoxO3a, and their phosphorylated forms were
detected in all regions of the growth plates of wild-type and myrAkt
transgenic mice, although higher levels of the phosphorylated forms
were detected in myrAkt transgenic mice than wild-type mice (Figs.
5I–P). These ﬁndings indicate that the Akt downstream signaling
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Fig. 3. Chondrocyte proliferation, cartilage matrix production, and cell growth in myrAkt transgenic mice. (A–E) BrdU labeling. Using sections of tibiae (A, B) and vertebrae (C, D) from
wild-typemice (A, C) and tg(L) (B, D) at E15.5, BrdU-positive cells were counted in the resting layers (upper boxes in A and B) and proliferating layers (lower boxes in A and B) of tibiae
and in vertebrae (E). BrdU-positive cells in vertebraewere counted in an arbitrary areawithout hypertrophic chondrocytes. (F–N) Increased extracellular matrix area in tg(L). Sections
of tibiae (F–I) and vertebrae (J–M) fromwild-type mice (F, H, J, L) and tg(L) (G, I, K, M) at E15.5 (F, G, J, K) and E18.5 (H, I, L, M) were stained with Safranin O (F, G, J, K) or reacted with
anti-type II collagen antibody (H, I, L, M), and the extracellular matrix area was calculated in the resting layers (upper boxes in F and G) and proliferating layers (lower boxes in F and
G) of tibiae and in vertebrae (N). Bars in H and I show the proliferating layer. Note that the proliferating layer in tg(L) (I) is short and disorganized as compared with wild-type mice
(H). (O) Micromass culture of limb mesenchymal cells. Mesenchymal cells from limbs of wild-type mice and tg(L) at E12.5 were cultured for 7 days and stained with Alcian blue. A
representative picture from three independent experiments is shown. (P) Cell sizes of chondrocytes were calculated in the resting, proliferating, and hypertrophic layers of tibiae and
in vertebrae. Relative values are shown as a percentage of the mean value inwild-type mice in E, N, and P. Data are presented as mean±S.E. of 5 mice. ⁎Pb0.05, ⁎⁎Pb0.01, ⁎⁎⁎Pb0.005
vs. wild-type mice. Scale bars: (A, B, F, G) 70 μm; (C, D, J, K) 50 μm; (H, I, L, M) 200 μm.
Fig. 2. Endochondral ossiﬁcation in limbs, cranial base, and vertebrae of myrAkt transgenic mice. Serial sections of limbs (A–H), cranial bases (I, J), and vertebrae (K, L) of wild-type
(wt) mice, tg(L) and tg(H) were examined by HE staining (A, D, K), HE and von Kossa staining (I), and in situ hybridization using Col2a1 (B, E), Pthr1 (C, F), Col10a1 (G, J, L), and Spp1 (H)
probes at E13.5 (A–C) and E15.5 (D–L). Note that the chondrocranium was markedly enlarged in tg(L) (I, J). Scale bars: (A–J) 500 μm; (K, L) 200 μm.
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Fig. 4. Endochondral ossiﬁcation, chondrocyte maturation and proliferation, and cartilage matrix production in dn-Akt transgenic mice. (A and B) Skeletal system at E15.5. Forelimbs
(A) and thoracic cages and vertebrae (B) of wild-type and dn-Akt transgenic mice are shown. (C–J) Histological analysis of hind limbs (C–F) and cranial bases (G–J) at E15.5. Serial
sections of hind limbs (C–F) and cranial bases (G–J) of wild-type mice (C, E, G, I) and dn-Akt transgenic mice (D, F, H, J) were examined by HE staining (C, D, G, H) and in situ
hybridization using Col10a1 probe (E, F, I, J). (K–O) Endochondral ossiﬁcation of vertebrae at E18.5. The skeletal system of vertebrae (K) and results of the histological examination by
HE staining (L, M) and in situ hybridization using Col10a1 probe (N, O) using serial sections of vertebrae of wild-type mice (L, N) and dn-Akt transgenic mice (M, O) are shown. In the
comparison of wild-type and dn-Akt transgenic F0 embryos, we always compared the littermates, because the developmental stages of wild-type F0 embryos were similar among
littermates but frequently not among unrelated wild-type F0 embryos as seen in Figs. 2I–L and Figs. 4G, I, L, N. (P–R) Reduced cartilage matrix production in dn-Akt transgenic mice.
Sections of tibiae from wild-type mice (P) and dn-Akt transgenic mice (Q) at E15.5 were stained with Safranin O, and extracellular matrix area was calculated in the resting layers
(upper boxes in P and Q) and proliferating layers (lower boxes in P and Q) of tibiae (R). (S) Chondrocyte proliferation. PCNA-positive cells were counted in the resting layers and
proliferating layers of tibiae. Relative values are shown as a percentage of the respective control. Data represent themean±S.E. of twowild-typemice and two dn-Akt transgenic mice.
Scale Bar: (A, B, K) 1 mm; (C–F) 500 μm; (G–J) 500 μm; (L–Q) 50 μm.
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Fig. 5. Detection of Akt, GSK3β, p70 S6K, and FoxO3a proteins and their phosphorylated forms in growth plates. Immunohistochemical analyses were performed on sections of
femurs of wild-type mice (A, C, E, G, I, K, M, and O) and tg(L) (B, D, F, H, J, L, N, P) at E18.5 using anti-Akt (A, B), anti-phosphorylated Akt (C, D), anti-GSK3β (E, F), anti-phosphorylated
GSK3β (G, H), anti-p70 S6K (I, J), anti-phosphorylated p70 S6K (K, L), anti-FoxO3a (M, N), and anti-phosphorylated FoxO3a (O, P) antibodies. The boxed regions are magniﬁed in the
respective insets. P; phosphorylated. Scale bar: 200 μm.
85S. Rokutanda et al. / Developmental Biology 328 (2009) 78–93pathways, Akt-GSK3, Akt-mTOR, and Akt-FoxO, are stimulated by the
activation of Akt in growth plates.
Mechanisms of the regulation of limb skeletal development by Akt
downstream signaling molecules
To elucidate the molecular mechanism of Akt functions in the
cellular processes of skeletal development, we further examined the
functions of the Akt downstream signaling pathways. To analyze
their functions in chondrocyte maturation, chondrocyte prolifera-
tion, cartilage matrix production, and cell growth in limb skeletons,
we examined the effect of treatment with lithium chloride, a GSK
inhibitor, or rapamycin, an mTOR-speciﬁc inhibitor, and overexpres-
sion of FoxO3a-TM (constitutively active form, in which the three
Akt phosphorylation sites were mutated) or dn-FoxO3a in organ
cultures of limb skeletons from wild-type mice at E15.5 (Fig. 6,
Supplementary Fig. 3A). First, we conﬁrmed the effectiveness of
lithium chloride and rapamycin by immunohistochemistry using
anti-β-catenin antibody and anti-phosphorylated p70 S6K antibody,
respectively. Treatment with lithium chloride accumulated β-catenin
to the nuclei and treatment with rapamycin reduced the phosphor-
ylation of p70 S6K (Figs. 6A, B). Treatment with either lithium
chloride or rapamycin reduced mineralization and reduced the
length of the hypertrophic layers compared with those on the side
treated with vehicle. Introduction of FoxO3a-TM or dn-FoxO3a
increased or decreased mineralization and increased or decreased
the length of the hypertrophic layers, respectively, compared with
those upon introduction of EGFP (Figs. 6C, D). These ﬁndings indicatethat GSK3, mTOR, and FoxOs all positively regulate chondrocyte
maturation.
Treatment with either lithium chloride or rapamycin reduced the
extracellular matrix area in the resting and proliferating layers of
femurs compared with those in vehicle-treated femurs. Introduction
of FoxO3a-TM or dn-FoxO3a increased or decreased the extracellular
matrix area, respectively, in resting and proliferating layers of femurs
compared with those in EGFP-infected femurs (Fig. 6E). In accordance
with the data from the organ cultures, cartilaginousmatrix production
was inhibited by treatment with either lithium chloride or rapamycin
and enhanced by the introduction of Fox03a-TM in the micromass
culture of primary chondrocytes (Supplementary Fig. 3C). Further, the
cell size of chondrocytes in the resting and proliferating layers of
femurs was reduced by treatment with rapamycin but not by
treatment with lithium chloride, FoxO3a-TM, or dn-FoxO3a compared
with that in the respective control (Fig. 6F). These ﬁndings indicate
that GSK3, mTOR, and FoxOs all positively regulate cartilage matrix
production, and that mTOR positively regulates cell growth.
To investigate chondrocyte proliferation, tibiae in organ culture
were labeled with BrdU. Treatment with either lithium chloride or
rapamycin severely reduced the number of BrdU-positive cells in
resting and proliferating layers compared with that in vehicle-treated
tibiae. Adenoviral introduction of FoxO3a-TM or dn-FoxO3a reduced or
increased the percentage of BrdU-positive cells, respectively, in the
resting and proliferating layers of tibiae compared with those in tibiae
infected with EGFP adenovirus (Fig. 6G, Supplementary Fig. 3D). These
ﬁndings indicate that GSK3 andmTOR positively regulate chondrocyte
proliferation while FoxOs negatively regulate it.
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Treatment with lithium chloride enhanced the expression of
TOP-ﬂash and Gli-reporter constructs (Figs. 7A, B), indicating that
lithium chloride enhances canonical Wnt signaling and hedgehog
signaling by inhibiting GSK3. To specify the effect of Akt-GSK3
signaling, therefore, we ﬁrst examined the effects of canonical Wnt
signaling and hedgehog signaling on chondrocyte maturation,
chondrocyte proliferation, extracellular matrix production, and cell
growth by organ culture of limb skeletons (Figs. 7C–G). Treatment
with Wnt3a or adenoviral introduction of dn-Tcf inhibited or
enhanced, respectively, endochondral ossiﬁcation and chondrocyte
maturation (Figs. 7C, D). Adenoviral introduction of Gli or dn-Gli
inhibited or enhanced, respectively, endochondral ossiﬁcation and
chondrocyte maturation (Figs. 7C, D). Therefore, both canonical Wnt
signaling and hedgehog signaling negatively regulated endochon-
dral ossiﬁcation by inhibiting chondrocyte maturation. The extra-
cellular matrix area was increased by either dn-Tcf or dn-Gli,
indicating that cartilage matrix production is negatively regulated
by canonical Wnt signaling and hedgehog signaling (Fig. 7E). Cell
size of chondrocytes was not affected by either signaling pathway
(Fig. 7F). Chondrocyte proliferation was enhanced by dn-Tcf but
inhibited by dn-Gli, indicating that canonical Wnt signaling inhibits
but hedgehog signaling enhances chondrocyte proliferation (Fig.
7G). Next, we examined the effect of lithium chloride in the
presence of both dn-Tcf and dn-Gli, which efﬁciently inhibited
expression of the respective reporter gene even in the presence of
lithium chloride (Figs. 7A, B). Treatment with lithium chloride
inhibited chondrocyte maturation, chondrocyte proliferation and
extracellular matrix production in the condition in which both
canonical Wnt signaling and hedgehog signaling were blocked (Figs.
7C–E, G). These ﬁndings indicate that the free pool of GSK3, which
is phosphorylated by Akt, MAPKAP-K1, and S6K (Frame and Cohen,
2001), has positive effects on chondrocyte maturation, chondrocyte
proliferation and cartilage matrix production in limb skeletons.
Mechanisms of the regulation of vertebral development by Akt
downstream signaling molecules
To investigate the downstream signaling pathways of Akt in ver-
tebral development, we performed organ culture using wild-type
vertebrae at E16.5. Treatment with the GSK3 inhibitors, SB216763 or
lithium chloride, did not affect the size of the vertebral bodies,
mineralization, chondrocyte hypertrophy, extracellular matrix area,
cell size of chondrocytes, nor chondrocyte proliferation, and treat-
ment with increased concentrations of lithium chloride also failed
to affect the size of the vertebral bodies and mineralization (Figs.
8A–E, Supplementary Fig. 4A, data not shown). In contrast, treatment
with rapamycin reduced the size of the vertebral bodies, mineral-
ization, number of hypertrophic chondrocytes, extracellular matrix
area, cell size of chondrocytes, and chondrocyte proliferation
compared with the respective parameter in vehicle-treated verte-
brae (Figs. 8A–E, Supplementary Fig. 3E). Adenoviral introduction
of FoxO3a-TM or dn-FoxO3a increased or decreased, respectively,Fig. 6. Functional analysis of Akt downstream signaling pathways in the development of lim
organ culture. Right tibiae (right panels) of wild-type mice at E15.5 were cultured with 20 m
left tibiae (left panels) were culturedwith vehicle as controls. The sections were reacted with
resting layers are magniﬁed in A to visualize the accumulation of β-catenin in the nuclei aft
skeletons after organ culture. Right limb skeletons (C and D, right panels) of wild-type mice a
TM adenovirus, or dn-FoxO3a adenovirus for 4 days, while the respective left limb skeleton
forelimb skeletons were stained with Alcian blue and Alizarin red and the lengths of the calci
stained with HE and the lengths of the hypertrophic layers of femurs were determined (D, bar
size of chondrocytes (F) in femurswere determined. (G) BrdU incorporation assay. Relative value
mice. ⁎Pb0.05, ⁎⁎Pb0.01, ⁎⁎⁎Pb0.005 vs the respective control. Scale bars: (A, B) 200 μm; (C) 2the size of the vertebral bodies, the area of mineralization, number
of hypertrophic chondrocytes, and extracellular matrix area, and
decreased or increased chondrocyte proliferation, respectively,
compared with the adenoviral introduction of EGFP (Figs. 8A–E,
Supplementary Fig. 3E).
Adenoviral introduction of either dn-Tcf or dn-Gli increased the
area of mineralization, the number of hypertrophic chondrocytes, and
extracellular matrix area compared with the adenoviral introduction
of EGFP, indicating that canonical Wnt signaling and hedgehog
signaling inhibit chondrocyte maturation and cartilage matrix pro-
duction in vertebrae (Figs. 8F–H). Adenoviral introduction of dn-Tcf or
dn-Gli enhanced or inhibited chondrocyte proliferation, respectively,
indicating that canonical Wnt signaling inhibits and hedgehog
signaling enhances chondrocyte proliferation in vertebrae (Fig. 8J).
However, treatment with lithium chloride showed no additional
effects on chondrocyte maturation, extracellular matrix area, and
chondrocyte proliferation in the presence of dn-Tcf or dn-Gli or in
the presence of both dn-Tcf and dn-Gli in vertebrae (Figs. 8F–H, J,
Supplementary Fig. 4B–D, F). Cell size of chondrocytes was not
affected by the presence of both dn-Tcf and dn-Gli, and treatment with
lithium chloride had no effect on cell size in the presence of dn-Tcf
or dn-Gli or in the presence of both dn-Tcf and dn-Gli (Fig. 8I,
Supplementary Fig. 4E).
The effects and expression of GSK3 in vertebral skeletons
To investigate the reason why the Akt-GSK3 pathway had no
signiﬁcant effects on the cellular processes in vertebrae, we examined
the effects of the constitutively active form of GSK3 (GSK3βS9A)
(Supplementary Fig. 5). Adenoviral introduction of GSK3βS9A inhibited
the expression of TOP-ﬂash and Gli-reporter constructs which was
enhanced byWnt3a and Shh, respectively (Supplementary Fig. 5A, B).
GSK3βS9A enhanced endochondral ossiﬁcation and chondrocyte
maturation and increased the extracellular matrix area, and reversed
Wnt3a- or Shh-induced inhibition of these cellular processes (Supple-
mentary Fig. 5C–E). GSK3βS9A inhibited chondrocyte proliferation and
reduced Wnt3a- or Shh-induced chondrocyte proliferation, while
GSK3βS9A had no signiﬁcant effect on the cell size of chondrocytes
(Supplementary Fig. 5F, G). Further, we examined the effect of lithium
chloride in the vertebrae, which was infected with adenovirus
expressing GSK3βS9A. The treatment with lithium chloride abolished
the effects of GSK3βS9A (Figs. 9A, B). These ﬁndings indicate that GSK3
has signiﬁcant effects not only in limb skeletons but also in vertebrae,
and that lithium chloride is effective in vertebrae if GSK3 is introduced.
To clarify the reason for the differential effectiveness of lithium
chloride in different skeletal parts, we compared GSK3β expression
in limb skeletons and vertebrae on the same section by immuno-
histochemistry (Figs. 9C–E). In the tibia, GSK3β expression was
increased at the proliferating layer, although the expression level
was lower than that in the hypertrophic layer, whereas increased
GSK3β expression was not observed in vertebrae, which lack the
proliferating layer. However, GSK3β expression was also increased in
hypertrophic chondrocytes in vertebrae (Fig. 9F). As hypertrophic
chondrocytes strongly expressed GSK3β in both limb skeletons and
vertebrae, we extracted protein from Th1-L7 vertebrae, in whichb skeletons by organ culture. (A, B) Effectiveness of lithium chloride and rapamycin in
M lithium chloride (lithium) (A) or 10 nM rapamycin (B) for 2 days, while the respective
anti-β-catenin antibody (A) or anti-phosphorylated p70 S6K antibody (B). Regions in the
er the treatment with lithium chloride. (C–F) Skeletal and histological analyses of limb
t E15.5 were cultured with 20 mM lithium chloride (lithium), 10 nM rapamycin, FoxO3a-
s (C and D, left panels) were cultured with vehicle or EGFP adenovirus as controls. The
ﬁed regions in ulnae were determined (C, bars). Sections of the hind limb skeletons were
s). Other sections were stained with safranin O, and extracellular matrix area (E) and cell
s are shown as a percentage of the respective control. Data are presented asmean±S.E. of 5
mm; (D) 50 μm.
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88 S. Rokutanda et al. / Developmental Biology 328 (2009) 78–93chondrocyte maturation had already occurred (Fig. 9F), and compared
it with the protein from limb skeletons by Western blot analysis (Fig.
9G). The protein levels of GSK3β, phosphorylated GSK3β, and GSK3α
were less than those in limb skeletons. In contrast, the protein levels of
mTOR, phosphorylated mTOR, p70 S6K, phosphorylated p70 S6K,FoxO3a, and phosphorylated FoxO3a were similar between limb
skeletons and vertebrae. Although the levels of hypertrophy in limb
skeletons and vertebrae affect the results of Western blot analysis, the
results combined with the data from immunohistochemistry indicate
that the unresponsiveness of vertebrae to lithium chloride is, at least
Fig. 8. Functional analysis of Akt downstream signaling pathways in vertebral development by organ culture. (A–E) Vertebral development through Akt downstream signaling
pathways. Vertebrae of wild-type mice at E16.5 were cultured with vehicle (Veh), 20 μM SB216763 (SB), 10 nM rapamycin (Rap), EGFP adenovirus, FoxO3a-TM adenovirus, or dn-
FoxO3a adenovirus. The vertebrae rostral to the second lumbar vertebra (L2), which had been cultured for 4 days, were stained with Alcian blue and Alizarin red (11–13th thoracic
vertebrae are shown in A), and sections of the vertebrae caudal to L2, which had been cultured for 2 days, were stained with HE (L6 is shown in B). Serial sections were stained with
safranin O, and the extracellular matrix area (C) and cell size of chondrocytes (D) in L6 were determined. (E) PCNA-positive cells in L6. Relative values are shown as the percentage of
the respective control. Data are presented as mean±S.E. of 5 mice. ⁎Pb0.05, ⁎⁎⁎Pb0.005 vs vehicle or EGFP control. (F–J) Vertebral development through canonical Wnt, hedgehog,
and Akt signaling pathways. Vertebrae of wild-type mice at E16.5 were cultured with EGFP adenovirus, dn-Tcf adenovirus, dn-Gli adenovirus, or dn-Tcf adenovirus plus dn-Gli
adenovirus with or without 20 mM lithium chloride (Li). In the infection of dn-Gli adenovirus, Cre adenovirus was also infected simultaneously to induce dn-Gli expression. Skeletal
preparations of 11–13th thoracic vertebrae (F) and L6 sections stained with HE (G) are shown. Serial sections of L6 were used for the analyses of extracellular matrix area (H), cell size
of chondrocytes (I), and PCNA staining (J). Relative values are shown as a percentage of that in EGFP-adenovirus-infected vertebrae. Data are presented as mean±S.E. of 3–5 mice.
⁎Pb0.05, ⁎⁎Pb0.01, ⁎⁎⁎Pb0.005 vs EGFP control, #Pb0.05 vs dn-Gli adenovirus. Scale bars: (A, F) 1 mm; (B, G) 50 μm.
Fig. 7. Functional analysis of GSK3 in canonical Wnt, hedgehog, and Akt signaling pathways in the development of limb skeletons. (A, B) Reporter assays using TOP-ﬂash (A) and
8×Gli-luc reporter constructs (B). The reporter vectors were transfected into chondrogenic ATDC5 cells, and EGFP, dn-Tcf, or dn-Gli adenovirus was infected into the ATDC5 cells after
24 h. Lithium chloride (Li) at the concentration of 20 mM was added 12 h after the infection, and luciferase activity was determined 48 h later. To induce dn-Gli expression, Cre
adenovirus (Cre) was infected 24 h before dn-Gli infection. Data are presented as means±S.E. of 4 wells. ⁎Pb0.05, ⁎⁎⁎Pb0.005 vs EGFP control. (C–F) Skeletal and histological
analyses of limb skeletons after organ culture. Right limb skeletons (C and D, right panels) of wild-type mice at E15.5 were cultured with 100 ng/ml of Wnt3a, dn-Tcf adenovirus, Gli
adenovirus, dn-Gli adenovirus, or dn-Tcf adenovirus plus dn-Gli adenovirus with 20 mM lithium chloride for 4 days, while the respective left limb skeletons (C and D, left panels)
were cultured with vehicle, EGFP adenovirus or dn-Tcf adenovirus plus dn-Gli adenovirus as controls. In the infection of dn-Gli adenovirus, Cre adenovirus was also infected
simultaneously to induce dn-Gli expression. The lengths of the calciﬁed regions in ulnae were determined (C, bars), and the lengths of the hypertrophic layers in femurs were
determined (D, bars). Other sections were stained with safranin O, and the extracellular matrix area (E) and cell size of chondrocytes (F) in femurs were determined. (G) BrdU
incorporation assay. Relative values are shown as a percentage of the respective control in C and D, and as a percentage of the EGFP-adenovirus-infected limb skeletons in E–G. Data
are presented as mean±S.E. of 3–5 mice. ⁎Pb0.05, ⁎⁎Pb0.01, ⁎⁎⁎Pb0.005 vs EGFP control, †††Pb0.005 vs dn-Gli adenovirus plus dn-Tcf adenovirus, #Pb0.05 vs dn-Gli adenovirus.
Scale bars: (C) 2 mm; (D) 50 μm.
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Fig. 9. Expression of GSK3 protein in limb and vertebral skeletons. (A, B) Organ culture of vertebrae. Vertebrae of wild-type mice at E16.5 were cultured with GSK3βS9A adenovirus or
GSK3βS9A adenovirus plus 20mM lithium chloride (Li) for 2 days, and sections were stained with HE (A). Serial sections were stained with safranin O, and the extracellular matrix area
was determined (B). ⁎⁎Pb0.01 vs GSK3βS9A adenovirus. (C–F) Immunohistochemical analysis using anti-GSK3β antibody. Sections from wild-type mice at E15.5 were reacted with
anti-GSK3β antibody (C, F). The boxed regions in C are magniﬁed in D and E. F shows 10th thoracic vertebra in another section. (G) Western blot analysis. Tissue lysates from limb (L)
and vertebral (V) skeletons of wild-type mice at E15.5 were resolved by electrophoresis, blotted, and reacted with anti-GSK3β, anti-phosphorylated GSK3β, anti-GSK3α, anti-mTOR,
anti-phosphorylatedmTOR, anti-p70 S6K, anti-phosphorylated p70 S6K, anti-FoxO3a, or anti-phosphorylated FoxO3a antibody. Immunoblot with anti-actin antibody was used as an
internal control. P; phosphorylated. Scale bars: (A, D–F) 200 μm; (C) 1 mm.
90 S. Rokutanda et al. / Developmental Biology 328 (2009) 78–93in part, due to a lack of the proliferating layer, in which GSK3β protein
expression was upregulated in limb skeletons.
Discussion
Although Akt1/Akt2-deﬁcient mice showed dwarﬁsm and the
retarded mineralization of the cartilaginous skeletons, the cellular
processes of chondrocyte maturation, chondrocyte proliferation,
cartilage matrix production, and cell growth were not examined in
themice (Peng et al., 2003). Thus, we ﬁrst investigated the functions of
Akt in skeletal development by analyzing the four cellular processes,
using chondrocyte-speciﬁc myrAkt or dn-Akt transgenic mice. Akt
positively regulated chondrocyte maturation, chondrocyte prolifera-tion, cartilage matrix production, and cell growth in the development
of limb skeletons and vertebrae, although chondrocyte maturation
and chondrocyte proliferation in the proliferating layer were inhibited
in limb skeletons of embryos that expressed myrAkt (Fig. 10). The Akt
downstream signaling molecules, GSK3β, S6K, and FoxO3a, were
expressed in the growth plates of wild-type mice, and the levels of
their phosphorylation were increased in the growth plates of myrAkt
transgenic mice compared with wild-type mice, indicating that Akt
regulates the phosphorylation of GSK3, mTOR, and FoxO3a in the
growth plates. We next examined the functions of the three Akt
downstream signaling pathways in the cellular processes of skeletal
development by organ culture. As Akt positively regulates mTOR and
negatively regulates FoxOs, our ﬁndings indicated that the Akt-mTOR
Fig. 10. Schematic representation of the function and predominance of Akt downstream
signaling pathways. The function and predominance of Akt downstream signaling
pathways, Akt-GSK3, Akt-mTOR, and Akt-FoxOs, in the cellular processes of skeletal
development, including chondrocyte maturation, chondrocyte proliferation, cartilage
matrix production, and cell growth are shown. Asterisks indicate that the Akt-GSK3
pathway has signiﬁcant effects on chondrocyte maturation, chondrocyte proliferation,
and cartilage matrix production in limb skeletons but not in vertebrae.
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Akt-FoxO pathway positively regulates chondrocyte proliferation but
negatively regulates chondrocyte maturation and cartilage matrix
production. As Akt negatively regulates GSK3, our ﬁndings indicated
that the Akt-GSK3 pathway negatively regulates chondrocyte matur-
ation, chondrocyte proliferation and cartilage matrix production in
limb skeletons but not in vertebrae, at least in part, due to the pre-
sence of the proliferating layer, in which GSK3 expression was
upregulated, in limb skeletons but not in vertebrae (Fig. 10). These
ﬁndings indicate that the Akt-mTOR pathway is dominant compared
with the Akt-GSK3 and Akt-FoxO pathways in chondrocyte matura-
tion and cartilage matrix production, that the Akt-mTOR and Akt-
FoxO pathways are dominant compared with the Akt-GSK3 pathway
in chondrocyte proliferation, that the Akt-mTOR pathway is respon-
sible for cell growth of chondrocytes, and that the Akt-GSK3 pathway
is involved in skeletal development of limb skeletons but not
vertebrae (Fig. 10). Thus, our ﬁndings demonstrate that Akt controls
the processes of endochondral ossiﬁcation and skeletal growth by
regulating chondrocyte maturation, chondrocyte proliferation and
cartilage matrix production through tuning the activities of mTOR,
FoxOs, and GSK3 depending on the skeletal part.
In tg(L), chondrocyte maturation and chondrocyte proliferation
were enhanced or inhibited depending on the skeletal part, indicating
that the Akt activation level or mode affects these processes in a
manner dependent on the skeletal part. This may be partly explained
by the previous ﬁnding that chronic activation of Akt induces feedback
inhibition of PI3K activity through both proteasome-dependent
degradation of insulin receptor substrate-1 (IRS-1) and inhibition of
transcription of IRS-1 as well as that of IRS-2 (Nagoshi et al., 2005).
Further, the distribution pattern of GSK3 protein in skeletal elements
may also explain the differential regulation of chondrocytematuration
and chondrocyte proliferation in the skeletal parts of tg(L). GSK3β
protein expression was ﬁrst upregulated in the proliferating layer and
further in the hypertrophic chondrocytes in limb skeletons, while it
was ﬁrst upregulated in the hypertrophic chondrocytes in vertebrae,
which lack the proliferating layer (Figs. 9C–F). Further, the treatment
with lithium chloride severely reduced BrdU uptake in the proliferat-
ing layer and severely inhibited chondrocyte maturation in limb
skeletons (Figs. 6C, D, G). Thus, the strong inhibition of GSK3 by Akt in
myrAkt transgenic mice may result in a decrease of chondrocytes
proliferation in the proliferating layer and inhibition of chondrocyte
maturation in limb skeletons but not vertebrae. It is also possible that
constitutive activation and/or over-activation of Akt affects the cell
cycle in a manner different from physiological Akt activation, because
chondrocyte proliferation was reduced in Igf1-deﬁcient mice but was
not enhanced in Pten mutant mice (Wang et al., 2006; Ford-
Hutchinson et al., 2007). Similar phenomena were observed in the
organ culture system. Treatment with lithium chloride or adenoviral
introduction of GSK3βS9A both inhibited chondrocyte proliferation
(Fig. 6G, Supplementary Fig. 5G), and treatment with Wnt3a oradenoviral introduction of dn-Tcf both enhanced chondrocyte pro-
liferation (Figs. 7G, 8J, Supplementary Fig. 5G).
GSK3 is involved in canonicalWnt signaling, hedgehog signaling, and
Akt signaling. The function of canonical Wnt signaling in endochondral
ossiﬁcation is complex, because expression of constitutively active β-
catenin or deletion of β-catenin in chondrocytes both delayed endo-
chondral ossiﬁcation (Guo et al., 2004). Further, lithium chloride or
SB216763 induced Fgf18 through the induction of β-catenin, leading to
the inhibition of chondrocyte maturation and chondrocyte prolifera-
tion (Kapadia et al., 2005). Our ﬁndings indicated that canonical Wnt
signaling inhibits endochondral ossiﬁcation, chondrocyte maturation,
chondrocyte proliferation, and cartilage matrix production in the phy-
siological condition (Figs. 7C–E,G, 8F–H, J). Hedgehog signaling inhibited
endochondral ossiﬁcation and chondrocyte maturation, enhanced
chondrocyte proliferation (Figs. 7C, D, G, 8F, G, J, Supplementary Figs.
5C, D, G) (St-Jacques et al., 1999), and reduced cartilage matrix
production (Figs. 7E, 8H). Further, GSK3 inhibited both canonical Wnt
signaling and hedgehog signaling (Figs. 7A, B, Supplementary Fig. 5)
(Kim and Kimmel, 2006). As treatment with lithium chloride or
SB216763 inhibits the kinase activity of GSK3 (Klein and Melton, 1996;
Stambolic et al., 1996; Coghlan et al., 2000), resulting in enhancement of
the canonical Wnt signaling and hedgehog signaling pathways in
addition to inhibition of GSK3 in the Akt-GSK3 pathway, the function of
theAkt-GSK3pathway in theprocesses of endochondral ossiﬁcation and
skeletal growth remained to be clariﬁed. Byblockingboth canonicalWnt
signaling and hedgehog signaling, however, we unraveled that Akt-
GSK3 signaling inhibits endochondral ossiﬁcation, chondrocytematura-
tion, chondrocyte proliferation, and cartilage matrix production in limb
skeletons but not in vertebrae. Our ﬁndings also showed that GSK3 is an
important positive regulator for chondrocyte proliferation in the pro-
liferating layer in limbskeletonsandexerts its positive effect in amanner
independent of hedgehog signaling, because GSK3 inhibits hedgehog
signaling (Figs. 6G, 7B, 9C–E). GSK3 upregulation in the proliferating
layer in limb skeletonsmay explainwhy limb skeletons growmore than
vertebrae during development.
Rapamycin inhibited adipogenic differentiation of 3T3-L1 cells and
myogenic differentiation of L6A1 cells (Yeh et al., 1995; Coolican et al.,
1997; Gagnon et al., 2001), but induced myogenic differentiation of
BC3H1 cells and the differentiation of vascular smooth muscle cells
(Jayaraman andMarks,1993;Martin et al., 2007), indicating thatmTOR
regulates adipogenic or myogenic differentiation positively or nega-
tively depending on the cultured cells and their differentiation stage.
Further, the role of mTOR in extracellular matrix production remained
to be examined. Our ﬁndings clearly showed that the Akt-mTOR
pathway positively and dominantly regulates chondrocyte maturation
and cartilage matrix production. As mTOR controls protein synthesis
through eIF4E and S6K (Hay and Sonenberg, 2004), the increased
cartilage matrix production in myrAkt transgenic mice is likely to be
due to the enhancedmRNA translation. FoxO1 inhibits adipogenic and
myogenic differentiation in vitro (Hribal et al., 2003; Nakae et al., 2003)
and FoxO4 represses smooth muscle cell differentiation in vitro (Liu et
al., 2005). However, our ﬁndings clearly showed that FoxOs promote
chondrocytematuration. Although FoxO3a has been shown to increase
the size of cardiac myocytes (Skurk et al., 2005), chondrocyte cell size
was not increased by FoxO3a-TM nor reduced by dn-FoxO. However,
FoxOs promoted extracellular matrix production.
Materials and methods
Generation of transgenic mice
To express the transgene in chondrocytes, cDNA encoding a HA-
tagged myrAkt or dominant negative Akt (dn-Akt) (Fujita et al., 2004)
was cloned into a vector containing Col2a1 promoter and enhancer
(Ueta et al., 2001). The dominant-negative Akt mutant (dn-Akt) has
alanine residues substituted for threonine at position 308 and serine at
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myristoylation sequence fused in-frame to the N terminus of the wild-
type Akt coding sequence that targets the fusion protein to the
membrane. An internal ribosomal entry site (IRES) followed by EGFP
DNA was inserted into the vector containing Col2a1 promoter and
enhancer at the 3′ end of myrAkt or dn-Akt cDNA (Fig. 1A, Supple-
mentary Fig. 2B). Expression levels of the transgenes were estimated
by the relative signal intensity of EGFP and Northern blot analysis.
Integration of the transgeneswas conﬁrmed by PCR using oligonucleo-
tides, 5′-AGGGCCCCTCTGCTAACCAT-3′ and 5′-CCCTTGCCCAGTAG-
TTTCAG-3′. Prior to the study, all experiments were reviewed and
approved by Nagasaki University Animal Care and Use Committee.
Skeletal and histological analyses
Alcian blue and Alizarin red staining was performed as described
previously (Ueta et al., 2001). Embryos at stages E13.5–18.5, as well as
limb and vertebral skeletons from organ culture, were ﬁxed in 4%
paraformaldehyde at 4 °C, dehydrated, and embedded in parafﬁn.
Sections (7 μm)were stained with hematoxylin and eosin (HE) or with
HE and vonKossa'smethod. Sectionswere also stainedwith safraninO,
and extracellularmatrix area and chondrocyte cell sizewere examined
using Image J software®. In situ hybridization was performed using
mouse Col2a1 (0.4 kb), mouse Col10a1 (0.65 kb), mouse Pthr1 (0.8 kb),
mouse Ihh (0.6 kb), mouse Spp1 (1.2 kb), and mouse aggrecan (1.5 kb)
antisense probes as previously described (Ueta et al., 2001; Yoshida et
al., 2004). For monitoring of EGFP signal, embryos were ﬁxed in 4%
paraformaldehyde at 4 °C and embedded into O.C.T compound
(SAKURA Finetek USA Inc., Torrance, CA), and frozen sections were
prepared and analyzed by ﬂuorescent microscopy.
Monitoring of proliferating cells
Mice at E15.5 were injected intraperitoneally with BrdU (50 μg/g
body weight) and were sacriﬁced 1 h later. Femurs and tibiae were
ﬁxed in 4% paraformaldehyde in 0.01M PBS (pH 7.4), and embedded in
parafﬁn. Detection of BrdU-positive cells in the cartilage was per-
formed using anti-BrdU monoclonal antibody (DAKO Japan, Tokyo,
Japan). For PCNA staining, sections were reacted with anti-PCNA
monoclonal antibody (Progen, Heidelberg, Germany).
Immunohistochemical analyses
Wild-type mice and myrAkt transgenic mice at E15.5 or E18.5 were
pretreated with Protein Block Serum-Free (DAKO, Japan), and then
incubated with goat anti-GFP (Abcam), rabbit anti-type II collagen
(Cosmo Bio, LSL, Japan), rabbit anti-Akt, rabbit anti-phosphorylated
Akt, rabbit anti-GSK3β, rabbit anti-phosphorylated GSK3β (Cell
Signaling Technology, Inc.) , rabbit anti-p70 S6K, rabbit anti-phos-
phorylated p70 S6K (Epitomics, Inc.), rabbit anti-FoxO3a, or rabbit
anti-phosphorylated FoxO3a (Upstate) antibody. The localization of
the ﬁrst antibody was visualized by incubationwith biotinylated anti-
rabbit IgG or anti-goat IgG antibody (Vector Laboratories), and then
with peroxidase-conjugated streptavidin (Vector Laboratories). The
peroxidase reaction was visualized with diaminobenzidine/hydrogen
peroxide solution (DOJINDO, Japan). As negative controls, normal
rabbit IgG or goat IgG (IBL) was used instead of the primary antibodies
and no signiﬁcant signals were detected (data not shown).
Cell culture
For micromass culture, limb buds from E12.5 embryos were
isolated and were digested in 0.1% trypsin and 0.1% collagenase at
37 °C for 30 min. Then, cells were resuspended in 40 μl drops at 2×107
cells/ml, and plated on 12-well plates. After culture for 1 h to allow the
attachment of cells, 2 ml of DMEM containing 10% FCS was overlaid.After culture for 7 days, Alcian blue staining was performed to detect
the production of cartilaginous substrates.
Organ culture
Limb and vertebral skeletons were isolated at E15.5 and E16.5,
respectively. BGJB medium (GIBCO Co. Ltd., New York, NY) supple-
mented with 0.25% FCS, 10 mM β-glycerophosphate, 0.6% bovine
serum albumin, and 15 μg/ml ascorbic acid was used for the culture,
and the medium was changed every day. After cultivation, samples
were ﬁxed with 4% paraformaldehyde, and then embedded into
parafﬁn. Forelimbs and the upper half of the spinal column, which
were cultured for 4 days, were stained with Alcian blue and Alizarin
red, and hind limbs and the lower half of the spinal column, which
were cultured for 4 days and 2 days, respectively, were subjected to
histological analysis. For BrdU labeling, tibiaewere labeledwith 10−5M
BrdU for 8 h after culture for 2 days and analyzed as described above.
We did not observe any deleterious effects on the tissues upon
treatmentwith lithium chloride at concentrations of 10–100mM,with
rapamycin at concentrations of 10–80 nM (data not shown), and with
SB216763 at concentrations of 5–20 μM (data not shown).
Adenovirus transfer
FoxO3a triple mutant (FoxO3a-TM), dn-FoxO3a, and GSK3βS9A
adenoviruses were gifts from K. Walsh (Skurk et al., 2005), and Gli,
dn-Gli and Cre adenoviruses were gifts from R. Nishimura (Osaka
University). In FoxO3a-TM, the three Akt phosphorylation sites, Thr-32,
Ser-253, and Ser-315, were replaced by alanine residues (Brunet et al.,
1999). The dn-FoxO3awas constructed by deleting the transactivation
domain of the C-terminus. In the constitutively activemutant ofGSK3β
(GSK3βS9A), the serine residue at position 9 was replaced by alanine.
The dn-Tcfwas constructed by cloning a partial cDNA fragment (amino
acids 188–303), which lacks the transactivation domain. LoxP se-
quences were integrated in the dn-Gli construct, and the adenovirus
expresses dn-Gli in the presence of Cre recombinase. They were
infected at a multiplicity of infection (MOI) of 10 or 20 for 24 h.
Immunoblotting and antibodies
Immunoblot analyses were performed as previously described
(Fujita et al., 2004). Proteins were resolved by 10% polyacrylamide gel
electrophoresis. The blots were ﬁrst incubated with rabbit anti-
phosphorylated Akt, rabbit monoclonal anti-GSK3β, rabbit anti-
phosphorylated GSK3β, rabbit anti-GSK3α, rabbit anti-mTOR, rabbit
anti-phosphorylated mTOR (Cell Signaling Tech., Beverly, MA), rabbit
anti-p70 S6K, rabbit anti-phosphorylated p70 S6K (Epitomics, Inc.),
rabbit anti-FoxO3a, rabbit anti-phosphorylated FoxO3a (Upstate
Biotech., Lake Placid, NY), or goat anti-actin (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA) antibody, and then with horseradish peroxidase-
conjugated anti-rabbit IgG (Cell Signaling Tech.) or anti-goat IgG (Santa
Cruz Biotechnology, Inc.) antibody.
Luciferase assay
Reporter assays were performed by transient transfection of 0.1 μg
of TOP-ﬂash (Upstate Biotech.) or 8xGli-luc (Sasaki et al., 1997), and
0.002 μg of pRL-CMV using the Dual Luciferase Reporter Assay System
(Promega, Madison, WI) as previously described (Fujita et al., 2004)
Luciferase activity was normalized to Renilla luciferase activity under
the control of the CMV promoter.
Statistical analysis
Statistical analyses were performed using Student's t-test. A P-
value of less than 0.05 was considered to be signiﬁcant.
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